Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A conversation with Dr. Alexandra-Chloé Villani about side effects experienced by melanoma patients undergoing immunotherapy
This report highlights the estimated number of new cases, prevalence, and survival statistics for cancer in the United States.
Summer has arrived and it’s a golden time to highlight July as UV Safety Awareness Month!
The American Academy of Dermatology designates the first Monday in May as Melanoma Monday.
May is National Melanoma/Skin Cancer Detection and Prevention Month.
We all have trillions of microorganisms that live throughout our bodies.
Lack of awareness of and participation in clinical trials are the biggest obstacles to bringing new skin cancer therapies to market.
Actor Ken Hudson Campbell lost his insurance in the SAG-AFTRA strike. He “burst into tears” from the financial support for treatment.
Research is conﬁrming that artiﬁcial intelligence and machine learning algorithms may revolutionize the speed of melanoma diagnosis.
Watch MRA CEO Dr. Marc Hurlbert and Army Veteran Andrew Smith discuss the risk of this skin cancer among the military and veterans.
Roughly nine out of ten skin cancers— including melanoma—are caused by unprotected exposure to UV rays.
Adjuvant immunotherapy can help reduce the likelihood of the skin cancer returning, but is more better or is less more?
Clear link between PFAS (“forever chemicals”), BPA exposures and a prior cancer diagnosis found in large national study.
Reducing the risk of this deadly skin cancer recurring after surgery is an important goal, notes the Melanoma Research Alliance.
Melanoma Research Alliance interviews Dr. Hussein Tawbi, who led a clinical trial on the immunotherapy drug Opdualag.
Melanoma skin cancer cells may spread, or metastasize, in the brain and cerebrospinal ﬂuid. Here’s a roundtable discussion on the topic.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.